Literature DB >> 418007

Binding of aminoglycoside antibiotics to human serum proteins. III. Effect of experimental conditions.

H Rosenkranz, M Scheer, W Scholtan.   

Abstract

The binding of several aminoglycoside antibiotics to human serum proteins was studied under varying experimental conditions. The protein binding was determined by means of equilibrium dialysis and, with sisomicin and gentamicin, also by the ultracentrifuge method in the presence and in the absence of Ca++ and Mg++ ions. The technical experimental procedure (dialysis, ultrafiltration, ultracentrifugation) has no effect on protein binding contrary to the physico-chemical conditions (varying concentrations of Ca++ and Mg++ ions). Under experimental conditions closely conforming to physiological conditions, the aminoglycosides of the kanamycin and neomycin series are not bound by the serum proteins, independent of the assay method used, whereas streptomycin is bound under these conditions. In the absence of divalent cations all the aminoglycosides studied were bound by the serum proteins to varying degrees; the fewer the OH groups contained in the aminoglycoside molecule the greater the rate of protein binding. At equal protein concentration, the albumin fraction of the serum has as great a binding capacity for sisomicin as gamma globulin. Alpha-1 and beta-1 globulin, however, are unable to bind sisomicin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 418007     DOI: 10.1007/bf01642159

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  19 in total

1.  [Binding of sisomicin and gentamicin to serum proteins (author's transl)].

Authors:  H Rosenkranz; M Scheer; W Scholtan
Journal:  Arzneimittelforschung       Date:  1976

2.  Effects of divalent cations on binding of aminoglycoside antibiotics to human serum proteins and to bacteria.

Authors:  C H Ramirez-Ronda; R K Holmes; J P Sanford
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

3.  In vitro assessment of tobramycin, a new aminoglycoside with anti-Pseudomonas activity.

Authors:  A Molavi; M Barza; W Cole; H Berman; L Weinstein
Journal:  Chemotherapy       Date:  1973       Impact factor: 2.544

4.  Serum protein binding of the aminoglycoside antibiotics.

Authors:  R C Gordon; C Regamey; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

5.  [Protein binding of gentamicin].

Authors:  E Vogt; G Lebek
Journal:  Schweiz Rundsch Med Prax       Date:  1973-04-03

6.  [Pharmacological and therapeutic properties of gentamicin. Experimental studies on the effect level, excretion, stability and therapeutic indications].

Authors:  P Naumann; W Auwärter
Journal:  Arzneimittelforschung       Date:  1968-09

7.  Comparative chemistry of some aminoglycoside antibiotics.

Authors:  D J Cooper
Journal:  Pure Appl Chem       Date:  1971       Impact factor: 2.453

8.  Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration.

Authors:  H Kurz; H Trunk; B Weitz
Journal:  Arzneimittelforschung       Date:  1977-07

9.  [Clinical-pharmacological studies with gentamycin].

Authors:  L Biró; E Iván; T Perényi; M Arr
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1969-10

10.  [Binding of sulfonamides to protein. 6. Determination of protein binding of sulfonamides by means of ultracentrifuge and gel filtration].

Authors:  W Scholtan
Journal:  Arzneimittelforschung       Date:  1965-12
View more
  3 in total

1.  Small Molecule Targeting of a MicroRNA Associated with Hepatocellular Carcinoma.

Authors:  Jessica L Childs-Disney; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2015-12-07       Impact factor: 5.100

2.  Ionic binding of aminoglycosides to human serum albumin in the absence of divalent cations. IV. Effect of structure, ph and concentration.

Authors:  W Scholtan; H Rosenkranz
Journal:  Infection       Date:  1978       Impact factor: 3.553

3.  Binding of sisomicin and streptomycin to human albumin.

Authors:  W Scholtan; H Rosenkranz; M Scheer
Journal:  Infection       Date:  1978       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.